| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |